tiprankstipranks
Bharat Rasayan Limited (IN:BHARATRAS)
:BHARATRAS
India Market
Want to see IN:BHARATRAS full AI Analyst Report?

Bharat Rasayan Limited (BHARATRAS) AI Stock Analysis

0 Followers

Top Page

IN:BHARATRAS

Bharat Rasayan Limited

(BHARATRAS)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
₹1,458.00
▼(-33.76% Downside)
Action:Reiterated
Date:01/21/26
Score is driven primarily by strong financial performance (growth, improving profitability, very low leverage, and improved cash flow), but is pulled down by very weak technicals (price below all major moving averages, negative MACD, and extremely oversold RSI/Stoch). Valuation is moderate with a modest dividend yield but a relatively higher P/E.
Positive Factors
Revenue & margin expansion
Sustained top-line growth with materially higher gross and net margins indicates durable demand and improved cost or pricing mix. Strong margins (33.8% gross; 12.0% net) support earnings resilience, allow reinvestment, and improve ability to absorb cyclical swings over the next several months.
Negative Factors
EPS decline
A significant drop in EPS despite revenue growth signals potential margin pressure, one-off charges, or dilution that undermines earnings consistency. This raises medium-term uncertainty for per-share profitability and complicates forecasting and investor return expectations.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue & margin expansion
Sustained top-line growth with materially higher gross and net margins indicates durable demand and improved cost or pricing mix. Strong margins (33.8% gross; 12.0% net) support earnings resilience, allow reinvestment, and improve ability to absorb cyclical swings over the next several months.
Read all positive factors

Bharat Rasayan Limited (BHARATRAS) vs. iShares MSCI India ETF (INDA)

Bharat Rasayan Limited Business Overview & Revenue Model

Company Description
Bharat Rasayan Limited manufactures and sells technical grade pesticides, intermediates, and bulk formulations in India. It offers insecticides, herbicides, fungicides, and intermediates. The company also exports its products. Bharat Rasayan Limit...
How the Company Makes Money
Bharat Rasayan makes money primarily by manufacturing and selling agrochemical products and related chemical intermediates. Its core revenue stream is the sale of technical-grade (active ingredient) pesticides and intermediates, typically supplied...

Bharat Rasayan Limited Financial Statement Overview

Summary
Strong fundamentals: revenue grew 12.3% (2024 to 2025), margins improved (net margin up to 12.0%), leverage is very low (debt-to-equity 0.08), and cash generation strengthened (operating cash flow to net income 1.19; free cash flow to net income 0.97).
Income Statement
80
Positive
Balance Sheet
75
Positive
Cash Flow
70
Positive
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue12.26B11.73B10.45B12.34B12.95B10.80B
Gross Profit3.90B3.96B3.24B3.95B3.69B3.30B
EBITDA2.06B2.01B1.38B2.06B2.66B2.45B
Net Income1.33B1.41B955.10M1.25B1.76B1.64B
Balance Sheet
Total Assets14.56B14.08B11.97B10.74B10.86B9.08B
Cash, Cash Equivalents and Short-Term Investments2.79B2.86B1.41B485.96M66.88M1.39B
Total Debt904.41M852.19M804.74M279.37M1.74B584.46M
Total Liabilities2.59B2.78B2.10B1.80B3.16B1.81B
Stockholders Equity11.97B11.30B9.88B8.93B7.70B7.27B
Cash Flow
Free Cash Flow-161.72M1.32B140.26M1.90B-1.21B1.40B
Operating Cash Flow249.00K1.68B410.76M2.13B-654.55M1.70B
Investing Cash Flow-173.93M-1.57B-897.00M-605.49M511.36M-1.53B
Financing Cash Flow23.25M41.22M489.57M-1.52B-247.85M-397.29M

Bharat Rasayan Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2201.25
Price Trends
50DMA
1393.95
Positive
100DMA
1654.32
Negative
200DMA
2121.99
Negative
Market Momentum
MACD
-12.15
Positive
RSI
49.03
Neutral
STOCH
27.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BHARATRAS, the sentiment is Positive. The current price of 2201.25 is above the 20-day moving average (MA) of 1412.08, above the 50-day MA of 1393.95, and above the 200-day MA of 2121.99, indicating a neutral trend. The MACD of -12.15 indicates Positive momentum. The RSI at 49.03 is Neutral, neither overbought nor oversold. The STOCH value of 27.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BHARATRAS.

Bharat Rasayan Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
₹48.27B-69.070.92%8.79%46.91%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹23.13B23.160.02%5.46%-27.45%
60
Neutral
₹68.60B24.870.93%-2.66%18.08%
59
Neutral
₹21.70B49.770.71%8.29%5.97%
51
Neutral
₹37.83B596.7628.35%
45
Neutral
₹36.67B8.301.77%4.86%-24.19%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:BHARATRAS
Bharat Rasayan Limited
1,391.75
-1,060.73
-43.25%
IN:INSECTICID
Insecticides (India) Limited
745.80
-0.67
-0.09%
IN:NACLIND
NACL Industries Ltd
161.50
-13.57
-7.75%
IN:NFL
National Fertilizers Ltd.
74.74
-20.26
-21.33%
IN:RALLIS
Rallis India Limited
248.20
-29.77
-10.71%
IN:RCF
Rashtriya Chemicals & Fertilizers Ltd.
124.35
-23.42
-15.85%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 21, 2026